Specialist Medtech Lawyer

We are committed to providing the highest quality service through a real understanding of your priorities and requirements, together with a common sense and commercial approach.

We manage and co-ordinate cross-border transactions, disputes and advisory projects involving our closely-knit network of partner law firms around the world.

Our approach to fees is designed to be flexible, recognising the differing needs of businesses depending on their stage in the development cycle.

1. Funding – from venture capital, private equity, angels, capital markets, grant funders, innovation agencies and NHS commissioners.
2. Corporate advice – company formation, shareholder agreements and disputes. 
3. Intellectual property protection and exploitation – including licensing and collaboration agreements, to give an edge over competitors and provide reassurance to investors.
4. Regulatory advice – including licence applications, compliance, classification (for medical devices and novel, advanced and borderline products) and dispute resolution.
5. Data governance – compliance solutions for data-driven products and services, including AI.
6. Commercial contracts – including franchising, supply and distribution agreements, technology transfer agreements, clinical trial agreements, research study agreements and infrastructure/platform/software-as-a-service (IaaS/PaaS/SaaS) agreements.
7. Consumer-facing terms and conditions – end user licence agreements, terms of service, privacy notices and privacy dashboards.
8. Commissioning models – how to buy and sell Medtech, digital health and devices into NHS and private clinical pathways, including strategic partnerships between providers and suppliers.
9. Joint ventures and collaborations – including involving domestic and international research organisations and hospitals.
10. Spinouts - advising on spinout transactions involving public sector and research institutions, including technology transfer and exploitation arrangements.
11. Transactions - disposals, mergers, acquisitions and restructuring.
     

Everybody uses technology, and we act for all kinds of businesses in the health and life sciences sectors including:

• Medtech, digital health and devices and life sciences businesses of all sizes, including clinical innovators, startups, SMES and established multi-national tech businesses.
• National NHS bodies such NHS England & NHS Improvement.
• NHS trusts, NHS foundation trusts and private hospitals.
• Digital consultation providers.
• Genetic analysis companies and biobanks.

• Advising  on legal and regulatory aspects of successfully adapting the GoodSAM emergency response app for use by the NHS to set up the NHS Volunteering Programme during the first COVID-19 lockdown. 
• Advising The Royal Wolverhampton NHS Trust on its partnership with Babylon to create the world’s first integrated digital health system and deliver joined-up care to the entire population of the city of Wolverhampton . 
• Advising Push Dr Limited, a provider of online doctor services, on Series A, B and C fundraisings. 
• Advising ADDVantage Technologies on its deal with Priory Group to offer online therapy programmes for common mental health conditions.
• Chairing the ethics and governance council for ARISE, an EU-funded multinational clinical study examining the feasibility, safety and efficacy of decellularised allogenic aortic heart valve matrices.
• Drafting all legal documentation associated with Medtech, Digital Health and Devices apps, for major remote consultation providers and startups alike, including end-user licence agreements, terms and conditions, privacy notices and cookies policies.
• Advising on and developing compliance solutions for the deployment of advanced AI technologies within the NHS
• Advising Rinicare, a digital health company focused on improving clinical risk prediction, on a data-sharing agreement with Manchester University NHS Foundation Trust, building upon work already taking place between the two parties to clinically evaluate Rinicare’s clinical risk prediction platform, STABILITY. The agreement marks a significant step forward in the use of AI technology in a healthcare setting and the impact that AI-driven patient monitoring can have on high-risk critical care patients.

Our lawyers are singled out in The Legal 500 UK and Chambers & Partners directory guides for healthcare and technology, having being recognised for their ‘brilliant service’ and ‘knowledge which is second to none’. Leading individuals from within the team are consistently ranked amongst the Best Lawyers in the United Kingdom for work across both healthcare and technology.

One of our team was invited to give oral evidence to the House of Commons Science and Technology Select Committee inquiry into genomics and gene editing in 2017.

“I have had the benefit of working with Hill Dickinson for the last three years and the value of that collaboration to our membership, and broader health technology community has been immense. Hill Dickinson provide a friendly and welcoming face in answering the often-complex legal questions involved in healthtech development. Without the help and active participation of Hill Dickinson, the healthtech companies touched by these programmes would not have gained key knowledge and knowhow needed to progress successfully.”
Neil Roberts, Chief Executive Officer, South East Health Technologies Alliance (SEHTA)

“Having Hill Dickinson’s insight and experience available to our health innovators has been hugely beneficial for our Propel@YH digital health accelerator programme, as it has given the SMEs involved a strong legal foundation to build their businesses.”
Dr Neville Young, Director of Enterprise and Innovation, Yorkshire & Humber AHSN

“The Walton Centre NHS Foundation Trust [a neurosciences centre of excellence based in Liverpool] is supporting a diverse innovation programme. Hill Dickinson colleagues have helped us to navigate complex data protection requirements, progress innovations towards commercialisation and facilitated links to like-minded healthcare and industry experts. We have really appreciated the company’s collaborative approach.”
Dr Andrew Rose, Head of Commercial Engagement and Marketing, The Walton Centre NHS Foundation Trust 

“Hill Dickinson have been partners in our journey since the beginning. As a healthcare startup with the ambition to change the way medicine is practised, we needed a partner who was comfortable at the cutting edge, grounded by NHS experience and able to support us at every step of growth. Hill Dickinson shaped our data protection strategy and guided us through to commercial contracts with approachable, clear and expert advice. We couldn’t be more pleased!”
Umar Naeem Ahmad, CEO, Abtrace